Search

everythinglearnresearchcommunity

for

Search:↓

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Diet can influence inflammatory skin diseases.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

Alopecia areata in elderly people is usually mild and responds well to treatment.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Thyroid issues can cause alopecia areata.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

Trichoscopy is better than the hair pull test for tracking alopecia areata.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Negative illness perceptions increase emotional distress, worsening OCD symptoms in alopecia areata patients.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Females have a higher lifetime risk of alopecia areata than males.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Vitamin D deficiency is common in children with and without alopecia areata, and more research is needed.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Most children with alopecia areata have patchy hair loss and common trichoscopic features like yellow and black dots.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Psychological stress is a major factor in the onset and severity of alopecia areata, with atopic individuals being more prone to develop it.

SH-MSCs gel reduced IL-6 and increased TGF-β, suggesting it could treat alopecia.